A bill to require reports on and investments in pharmaceutical supply chain resiliency to reduce reliance on the People's Republic of China for finished pharmaceutical products and active pharmaceutical ingredients.
Pharmaceutical Supply Chain Security Act
This bill directs certain agencies to report on and reduce the role of China in pharmaceutical supply chains.
Specifically, the Food and Drug Administration must report on pharmaceutical products and ingredients for which China supplies more than 20% of the quantities available in the United States. In addition, the President must develop a strategy to address the role of China in the global pharmaceutical supply chain and related threats to national security. The United States International Development Finance Corporation must also support manufacturing projects that promote the security of pharmaceutical supply chains, reduce reliance on China, and foster cooperation with other countries.
Introduced in Senate
Read twice and referred to the Committee on Foreign Relations.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line